Navigation Links
Success Factors and Failure Points for Oncology New Product Launches

CHAPEL HILL, N.C., July 22, 2011 /PRNewswire/ -- The oncology therapeutic area continues to be an active sector for new pharmaceutical product investment and launches as next generation oncology therapies find success in a competitive marketplace. With more new targeted oncology products finding success, organizations in the oncology therapeutic area are facing a crowded marketplace that is pushing them to rethink the factors that play the biggest role in the current launch environment.

In a new wide-ranging research project that explores the pivotal success factors and failure points facing new oncology product launches, Best Practices, LLC established a critical core set of factors that can make or break a market entry for cancer products as well as other types of therapies. As more products target the same disease mechanism, the need for differentiation has become vital and, likewise, the price of oncology products has made it critical to present a compelling value argument to payers.

The benchmarking study presents a framework for launch success:  the ability to differentiate, a defined target patient population, investment in launch activities, engagement of thought leaders, education of key stakeholders, demonstration of value, utilization of new technologies and avoidance of launch pitfalls. The report, Success Factors and Failure Points in Oncology Product Launches, examines each of these key launch issues and offers launch leaders two perspectives: an oncology segment and a total benchmark class segment that includes other therapeutic areas.

In addition to delivering qualitative and quantitative insights on each aspect of this launch framework, the 182-page report presents launch leaders' perspectives on the current and future risk levels for an array of pitfall factors that can affect a new product launch.

To download a complimentary study excerpt, go to:

Best Practices, LLC used both field surveys and interviews to complete this study. In all, 44 managers and executives at 38 leading bio-pharma companies participated in the survey.  In-depth interviews were conducted with leaders from six organizations who have decades of experience with pharmaceutical launches.

Topics covered in this study include:

  • Winning on Differentiated Product Positioning
  • Winning a Physician's Initial Trial of a New Product
  • Articulating Benefits that Shape Positive Market Perception
  • New Product Pricing Strategy
  • Thought Leader Engagement
  • Early Physician Education
  • Payer Education
  • Patient Education and Advocacy
  • Preparing Market Constituents
  • Access Insights & Success Factors
  • Winning Hospital Formulary Access
  • Resource Allocation for Key Stakeholders
  • Investment Requirements, Resource Allocation & Timing
  • Internal Launch Readiness
  • New Technologies for Informing Patients and Physicians
  • Pitfalls and Stumbling Blocks
  • Demonstrating Efficacy
  • Rating Different Safety Dimensions


Best Practices, LLC serves 48 of the world's 50 top companies in the pharmaceutical industry for more than 17 years.  For more information about the company, go to

SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Early Stage Commercialization: Keys to Successful New Product Launch
2. Diplomat Specialty Pharmacy 2011 Patient Satisfaction Survey Results Affirm Success of Companys Patient Focused Model
3. Chinese Biopharmaceutical Association Successfully Holds 16th Annual Conference
4. Unilife Successfully Completes Industrialization of Unifill Syringe
5. Medical Messenger Partners With to Provide Key Elements of Meaningful Use Success
6. Jubilant and AstraZeneca Announce Successful Delivery of Early Milestones in Drug Discovery
7. Particle Sciences Develops Proprietary Nasal Delivery Formulation Used in Neurelis Recently Announced Successful Phase I Pharmacokinetic Study of NRL-01 (intranasal diazepam)
8. Altair Semiconductor Successfully Demonstrates its LTE Chipset Speeds and Service for China Mobile Executives
9. Accuray Successfully Completes Acquisition of TomoTherapy
10. Educating Key Stakeholders to Support a Successful Pharmaceutical Product Launch
11. Crux Successfully Completes Funding for Advanced Filter for PE Prevention
Post Your Comments:
(Date:11/30/2015)... -- Varian Medical Systems (NYSE: VAR ) has signed a ... Hospitals Group, the largest hospital chain in India ... in the country. The MoU was signed by Dr. K. ... Kakkar , Varian,s India managing director, in ... , Varian intends to deploy its Access to Care program by ...
(Date:11/30/2015)... , Nov. 30, 2015  Novartis will demonstrate ... the 57 th American Society of Hematology (ASH) ... and myelomas as well as supportive care, including key ... to personalized cell therapies. The ASH Annual Meeting will ... . Novartis Oncology . "We will ...
(Date:11/30/2015)... KIRKLAND, Wash. , Nov. 30, 2015 /PRNewswire/ ... of Post-Processing services, is pleased to announce a ... of medical imaging services. Building on its ISO-9001:2008 ... adopted and implemented comprehensive Core Lab protocols and ... wide variety of research activities.  Their Core Lab ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... November 30, 2015 , ... The Foundation for Breast and ... prevention—is joining forces with the award-winning creator and writer of Downton Abbey Julian ... 2015 at the Union League of Philadelphia. , The benefit, titled “An ...
(Date:11/30/2015)... ... , ... The American Society for Clinical Pathology (ASCP) announced today that it ... Nov. 30, ASCP shared its “Give a minute. Get tested. Find a cure.” icon ... of getting tested for HIV. , ASCP has asked members to replace their Facebook, ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... their exclusive channel partner for the Nutraceutical Specialties products into oral solid dosage ... effective immediately. , “We are pleased to announce our expanded distribution agreement ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... magazine, quoted Michael Hansen, Ph.D., a senior scientist at Consumer Reports as supporting ... so for a child’s exposure limits. , The original Nov 2015 CR story ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... for the last 15 years, announced today that Michigan-based Family Health Center (FHC) ... care for over 45 years, FHC was awarded the largest Affordable Care Act ...
Breaking Medicine News(10 mins):